Back to search

Article

Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis

2023-05-16

Abstract excerpt

Immune checkpoint inhibitors (ICIs) are a remarkable advancement in cancer therapeutics; however, a substantial proportion of patients develop severe immune-related adverse events (irAEs). Understanding and predicting irAEs is a key to advancing precision immuno-oncology. Immune checkpoint inhibitor-mediated colitis (IMC) is a significant complication from ICI and can have life-threatening consequences. Based on c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7947bfe-6596-5b7a-ba88-c834f961cc33
DOI
10.1101/2023.05.15.23289680
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisDOI 10.1101/2023.05.15.23289680
Select a neighboring publication to make it the new centre.